THIOBENZIMIDAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND USE THEREOF
申请人:Korea University Research and Business Foundation
公开号:EP4230204A1
公开(公告)日:2023-08-23
The present invention relates to a thiobenzimidazole derivative or a pharmaceutically acceptable salt thereof, and a composition for preventing or treating cancer, comprising the derivative as an active ingredient. The thiobenzimidazole derivative of the present invention exhibits cell toxicity by blocking the cell cycle of a cancer cell and inducing apoptosis when administered to an individual, as the derivative inhibits tubulin polymerization by being activated in the cancer cell, and, thus, the derivative can be used for prevention or treatment of cancer, desirably for prevention or treatment of triple-negative breast cancer.
本发明涉及一种硫苯并咪唑衍生物或其药学上可接受的盐,以及一种用于预防或治疗癌症的组合物,所述组合物包含所述衍生物作为活性成分。本发明的硫苯并咪唑衍生物在给药于个体时,通过阻断癌细胞的细胞周期并诱导凋亡来表现出细胞毒性,因为所述衍生物在癌细胞中被激活后抑制微管蛋白聚合,因此,所述衍生物可用于预防或治疗癌症,尤其适用于预防或治疗三阴性乳腺癌。